|
RNAC Cartesian Therapeutics Inc 1453687 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$15,769,000.00 |
| Balance Sheet |
|
Current Assets
|
$153,615,000.00 |
|
Assets
|
$318,628,000.00 |
|
Current Liabilities
|
$20,550,000.00 |
|
Liabilities
|
$443,854,000.00 |
|
Equity
|
$-125,226,000.00 |
|
Shares Out
|
30037962.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-43,217,000.00 |
|
Investing Cash Flow
|
$-299,000.00 |
| Market Analysis |
Market Cap
|
$307,288,351.26 |
|
Price
|
$10.23 |
|
PB
|
1.24 |
|
EPS
|
0.47 |
|
FCF
|
$-43,516,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:44 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:35 |
|
| Apr |
May |
Jun |
| 2026-03-09 |
-5.02 |
2026-04-30 |
-1.46 |
|
|
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
0.50 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-1.38 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RNAC documents filed with the SEC.
RNAC Filings
Clear
